Company intelligence / Profile preview

OTE North America

Inwood, New York, United Stateshbw.citeline.com ↗

Ownership: Private
Development stage: Other

Overview

Oté North America develops and markets FDA-cleared multi-purpose solutions for soft (hydrophilic) contact lenses. Their flagship product, OTE MPS 045 Multi-Purpose Lens Care Solution, is substantially equivalent to Bausch & Lomb Biotrue® Multi-Purpose Solution. The company operates as the US branch of the Dutch-based Oté group, which specializes in innovative eye care products and has expanded internationally since 2015.

Therapeutic areas: Ophthalmology
Modalities: Device
Industry: Consumable Medical Devices

Partnerships

Supplier relationship with Oté Pharma Sol BV

Beyond the preview

Go deeper on OTE North America.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OTE North America.

Explore the full profile